Epiretinal Membrane Surgery in Patients With Multifocal Versus Monofocal Intraocular Lenses

Lee, Jong‐Young; Joo, Kwangsic; Park, Sang Jun; Woo, Se Joon; Park, Kyu Hyung

doi:10.1097/iae.0000000000003255

Cited by 7 publications

(5 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Watanabe et al [25] demonstrated that images viewed through multifocal IOLs were warped and out of focus. Lee et al [26] reported that with multifocal IOLs in Values are presented as mean ± standard deviation or number (%). QoV = quality of vision; IOL = intraocular lens.…”

Section: Resultsmentioning

confidence: 99%

Combined Vitrectomy and Cataract Surgery with Enhanced Monofocal Intraocular Lens Implantation

Hwang

Lee²,

Ahn³

et al. 2023

J Retin

View full text Add to dashboard Cite

Purpose: To evaluate the visual outcomes and satisfaction of patients with enhanced monofocal intraocular lenses (IOL) implanted during phacovitrectomy. Methods: A university hospital, retrospective, non-comparative pilot study. The main outcome measures were uncorrected near visual acuity (UNVA), uncorrected intermediate visual acuity (UIVA), uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), and the image through the IOL to assess the quality of the intraoperative view. Patient satisfaction was assessed using a 3-month follow-up questionnaire.Results: This study included 20 eyes that underwent phacovitrectomy with implantation of an enhanced monofocal IOL (TECNIS Eyhance ICB00; Johnson & Johnson Surgical Vision, Santa Ana, CA, USA). The most common cause of vitrectomy was epiretinal membrane in 15 eyes (75%), followed by mild vitreous hemorrhage in three eyes (15%) and vitreous opacity in two eyes (10%). There was no difference between the view through the enhanced monofocal IOL and that through the monofocal IOL (TECNIS ® ZCB00; Johnson & Johnson Surgical Vision, Santa Ana, CA, USA). The mean 3-month postoperative CDVA, UDVA, and UIVA were 0.10 ± 0.15, 0.15 ± 0.11, and 0.30 ± 0.14 (logarithm of the minimum angle of resolution), respectively; the improvements were statistically significant (p < 0.001). The mean 3-month postoperative UNVA was 0.50 ± 0.12, showing no significant difference (p = 0.803). The mean general and intermediate quality of vision scores were 9.13 ± 0.73 and 7.4 ± 0.25, respectively (0: very dissatisfied; 10: very satisfied). Out of 20 patients, 17 (85%) were satisfied with their intermediate vision; some reported glare (2 [10%]) and halo (1 [5%]). Conclusions: Combined vitrectomy and cataract surgery with enhanced monofocal IOL implantation led to favorable visual outcomes at far and intermediate distances and high patient satisfaction.

show abstract

Section: Resultsmentioning

confidence: 99%

Combined Vitrectomy and Cataract Surgery with Enhanced Monofocal Intraocular Lens Implantation

Hwang

Lee²,

Ahn³

et al. 2023

J Retin

View full text Add to dashboard Cite

show abstract

“…There have been reports that the light-splitting nature of multifocal IOLs can reduce contrast sensitivity, especially in low-mesopic environments 17 – 19 . In addition, it has been reported that implantation of multifocal IOLs may cause disturbance of visualization during subsequent ERM removal surgery 9 , 10 . Although there have been no human clinical reports on macular visualization during vitrectomy surgery, the Eyhance IOL showed better macular visibility in the Gullstrand eye model, which can be considered an advantage over the multifocal IOL 20 .…”

Section: Discussionmentioning

confidence: 99%

Short-term clinical outcomes after implantation of monofocal intraocular lens with enhanced intermediate function in eyes with epiretinal membrane

Chung,

Nam,

Jang

et al. 2023

Sci Rep

View full text Add to dashboard Cite

Our study evaluated the clinical outcomes after implantation of a monofocal intraocular lens (IOL) with enhanced intermediate function in eyes with epiretinal membrane (ERM). Patients with preexisting ERM who underwent cataract surgery with implantation of monofocal IOL with enhanced intermediate function were included retrospectively. According to the ERM grade and central subfield thickness (CST) obtained from preoperative optical coherence tomography, patients were divided into non-fovea-involving and fovea-involving ERM groups. At 1 month after surgery, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), contrast sensitivity, defocus curve, and satisfaction questionnaire were evaluated. Postoperative clinical findings were compared with age-matched controls without ERM. A total of 50 patients’ eyes (28 and 22 in the non-fovea-involving and fovea-involving ERM groups, respectively) were compared with 42 control eyes. One month post-surgery, significant differences in UDVA, CDVA, and CST (corrected P was < 0.001, = 0.001, and < 0.001, respectively) were observed between the fovea-involving ERM and control group; however, no significant differences in UIVA and UNVA were observed between the two groups. Contrast sensitivity showed inferior results in the fovea-involving group without significance. Photic phenomena were reported less in the fovea-involving group than in the non-fovea-involving group. More than 70% of patients in both ERM groups were satisfied. Implantation of monofocal IOL with enhanced intermediate function could be a good option for patients with ERM that need intermediate vision.

show abstract

“…In this study, the median opinion regarding MF-IOL implantation in eyes with epiretinal membranes was “slightly disapprove”; 52.3% of the opinions were disapproving, possibly due to the idea that this difficulty can be overcome with an adequate viewing system and an increase in surgical experience with these situations. Recently, in the presence of MF-IOL in epiretinal surgery, it was reported that the surgical time was longer for the procedure to create a membrane edge or flap using retinal microforceps, but the surgical outcome was similar [ 23 ].…”

Section: Discussionmentioning

confidence: 99%

Analysis of Korean Retinal Specialists’ Opinions on Implanting Diffractive Multifocal Intraocular Lenses in Eyes with Underlying Retinal Diseases

Lee

Kong

Sohn

et al. 2022

JCM

View full text Add to dashboard Cite

Multifocal intraocular lenses (MF-IOLs) are increasingly implanted as the need for good near- and intermediate-distance vision increases. Although retinal disease is known to be a relative contraindication for MF-IOL implantation, there are no detailed guidelines for MF-IOL implantation with respect to the type and severity of retinal diseases/statuses. In this study, because retinal diseases can affect the performance of MF-IOLs, we analyzed the opinions of 111 retinal specialists, who were members of the Korean Retina Society, on the implantation of diffractive MF-IOLs in eyes with 15 retinal diseases/statuses using a web-based survey. For each underlying condition, retinal specialists were asked to rate their approval regarding implantation of MF-IOLs on a scale from 1 (completely disapprove) to 7 (completely approve), under the assumption that there were no known contraindications except for a given retinal disease/status. As a result, retinal specialists disapproved MF-IOL implantation (median value of Likert score < 4) in the eyes with wet age-related macular degeneration, dry age-related macular degeneration with geographic atrophy, proliferative diabetic retinopathy, nonproliferative diabetic retinopathy with macular edema, previous macula-off retinal detachment, previous retinal vein occlusion, and epiretinal membrane, but the scores varied by disease/status. The factors that affected the specialists’ opinions were the type of practice and the frequency of MF-IOL implantation (p = 0.013 and p = 0.021, respectively; one-way ANOVA).

show abstract

Epiretinal Membrane Surgery in Patients With Multifocal Versus Monofocal Intraocular Lenses

Cited by 7 publications

References 31 publications

Combined Vitrectomy and Cataract Surgery with Enhanced Monofocal Intraocular Lens Implantation

Combined Vitrectomy and Cataract Surgery with Enhanced Monofocal Intraocular Lens Implantation

Short-term clinical outcomes after implantation of monofocal intraocular lens with enhanced intermediate function in eyes with epiretinal membrane

Analysis of Korean Retinal Specialists’ Opinions on Implanting Diffractive Multifocal Intraocular Lenses in Eyes with Underlying Retinal Diseases

Contact Info

Product

Resources

About